---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-23-041393"
form_type: "8-K"
ticker: "AIM"
cik: "0000946644"
company_name: "AIM ImmunoTech Inc."
filed_at: "2023-11-15T23:59:59+00:00"
generated_at: "2026-06-08T03:06:12.488668+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.3
calibrated_materiality_score: 0.3
confidence: "low"
source: SEC EDGAR
---

# AIM Immunotech files 8-K with Q3 2023 update presentation; no specific data available in filing text

## Summary
- Filing includes a company presentation as Exhibit 99.1 titled Q3 2023 Update Conference Call and dated November 15, 2023.
- Presentation is furnished under Regulation FD and not filed; no financial or operational details are provided in the 8-K body.
- No specific earnings, revenue, EPS, or guidance figures are available from the furnished content as seen in the filing.
- Ticker: AIM; stock listed on NYSE American.

## SEC filing metadata
- accession: 0001493152-23-041393
- form_type: 8-K
- ticker: AIM
- cik: 0000946644
- company_name: AIM ImmunoTech Inc.
- filed_at: 2023-11-15T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.3
- calibrated_materiality_score: 0.3
- confidence: low
- sec_items: 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/946644/000149315223041393/0001493152-23-041393-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/946644/000149315223041393/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-23-041393
- JSON: https://secwatch.observer/filing/0001493152-23-041393.json
- Plain text: https://secwatch.observer/filing/0001493152-23-041393.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.